The Canadian AI Index

Companies / Biossil

Biossil

Biossil is a health and biotech AI company based in Toronto, Ontario. It had raised C$309.3M as of November 2026, most recently a US$153M venture round in September 2026 led by OpenAI Startup Fund.

AI platform to identify and revive failed late-stage drug candidates.

biossil.co

Suggest a correction

Founded
2023
HQ
Toronto, ON
Category
Health/Bio AI
Status
Active
Disclosed raised
C$309.3M

Funding history

RoundDateAmountInvestors
Venture roundSep 28, 2026 US$153MOpenAI Startup Fund (lead); Founders Fund, Quiet Capital, Modern Capital, Golden Ventures, Panache Ventures, Duke University endowment, Abu Dhabi Investment Council. About C$216M, at a US$1B valuation. Led by the OpenAI Startup Fund, which provided the majority of the round; Founders Fund, Quiet Capital, Modern Capital, Golden Ventures, Panache Ventures, Duke University's endowment and the Abu Dhabi Investment Council participated. Round not named and not formally announced: reported by The Globe and Mail on Sep 28, 2026 and confirmed by CEO Anthony Mouchantaf. An August 2026 Corporations Canada filing created the new preferred share class.
Series BApr 21, 2026 US$43MFounders Fund and OpenAI Startup Fund (co-leads). Series B co-led by Founders Fund and the OpenAI Startup Fund. Closed in fall 2025 and announced Apr 21, 2026, when Biossil came out of stealth with about US$68.7M raised in total.
Series A2024 US$22MFounders Fund (lead). round type approximated; Founders Fund led
Seed2023 C$3.7MStaircase Ventures (lead); Golden Ventures, Panache Ventures. 3-yr stealth; amounts per Globe/The Logic

Founders

In the newsletter

Sources

Data as of November 10, 2026.

Support the Index by subscribing to the newsletter.

This database updates weekly. Get the update, plus the week's Canadian AI news, by email.

Subscribe on Substack

Opens Substack in a new tab.